CEO Adrian Rawcliffe sold $26K of Adaptimmune Therapeutics Plc

Sold$26,464

$5.33Price

4,967Shares

−42%Stake

What ADAP did after the filing

Prices for ADAP after this filing aren't in yet.

Traded Mon, Jan 4. Filed Tue, Jan 5, 4:00 PM ET, after the close. Not investment advice.